FREMONT, CA--(Marketwired - Nov 11, 2015) - Optovue, Inc., a global leader in the development and commercialization of optical coherence tomography (OCT) and OCT angiography technology for the eye ...

LAS VEGAS, NV--(Marketwired - Sep 14, 2016) - Optovue, the global leader in the development of optical coherence tomography (OCT) and OCT angiography (OCTA), introduced Vault Mapping for all iSeries ...

Optovue announced the launch of The Optometric Medical Model Initiative. TOMMI is an educational program intended to help physicians transition to a medical practice model through live workshops, ...

FREMONT, Calif.--(BUSINESS WIRE)--Optovue, the global leader in the development of optical coherence tomography (OCT) and OCT angiography (OCTA), is the first company to offer higher density OCTA ...

The U.S. Food and Drug Administration has granted 510(k) clearance to Optovue for its iFusion combination imaging platform, according to a company news release. The iFusion offers modular pairing of ...

The FDA has cleared Optovue to market its epithelial thickness mapping software in the U.S. Eye doctors can use the updated software and accompanying optical coherence tomography device to ...

FREMONT, Calif. & DUBLIN, Calif.--(BUSINESS WIRE)--Optovue Inc. and Carl Zeiss Meditec Inc. announced today that they have signed a settlement agreement resolving two pending Federal District Court ...

Optovue, a global leader in the development and commercialisation of optical coherence tomography angiography (OCTA), announced commercial availability of AngioAnalytics, the next generation of its ...

A looming patent litigation fight over optical coherence tomography (OCT) systems between the US subsidiary of Germany’s Carl Zeiss Meditec and the far smaller Californian company Optovue has been ...

AngioVueHD Enhances Image Resolution Over Extended Field-of-View. FREMONT, Calif.--(BUSINESS WIRE)--Optovue, the global leader in the development of optical coherence tomography (OCT) and OCT ...